| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,995 |
11,056 |
$802K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,738 |
4,783 |
$242K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,776 |
2,599 |
$158K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,704 |
2,547 |
$157K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,715 |
4,441 |
$125K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,112 |
1,959 |
$117K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,261 |
2,908 |
$110K |
| 99173 |
|
5,390 |
5,006 |
$96K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,118 |
1,921 |
$88K |
| D1208 |
Topical application of fluoride, excluding varnish |
5,714 |
5,386 |
$73K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,115 |
1,060 |
$65K |
| 92551 |
|
5,320 |
4,935 |
$65K |
| 3008F |
|
7,224 |
6,699 |
$62K |
| 99215 |
Prolong outpt/office vis |
646 |
555 |
$50K |
| 80061 |
Lipid panel |
1,751 |
1,632 |
$25K |
| 99205 |
Prolong outpt/office vis |
131 |
124 |
$23K |
| 83655 |
|
1,680 |
1,564 |
$22K |
| 90658 |
|
3,585 |
3,310 |
$20K |
| 85018 |
|
3,816 |
3,537 |
$10K |
| 36416 |
|
3,590 |
3,390 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
65 |
65 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
222 |
199 |
$6K |
| 90670 |
|
1,183 |
1,112 |
$5K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
184 |
76 |
$3K |
| 96127 |
|
840 |
764 |
$3K |
| 90657 |
|
667 |
628 |
$3K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
28 |
24 |
$3K |
| 90680 |
|
598 |
561 |
$2K |
| 90723 |
|
564 |
534 |
$2K |
| 90648 |
|
578 |
548 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
33 |
25 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
99 |
95 |
$2K |
| 90633 |
|
343 |
326 |
$1K |
| 90651 |
|
177 |
163 |
$1K |
| 86580 |
|
165 |
146 |
$996.04 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
51 |
30 |
$992.72 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
18 |
$671.98 |
| 94010 |
|
12 |
12 |
$350.02 |
| 81002 |
|
111 |
93 |
$321.33 |
| 80305 |
|
38 |
27 |
$313.80 |
| 99442 |
|
16 |
14 |
$266.58 |
| 90734 |
|
57 |
56 |
$253.10 |
| 90697 |
|
28 |
25 |
$212.83 |
| 90619 |
|
13 |
13 |
$204.00 |
| 90671 |
|
13 |
12 |
$169.50 |
| 95117 |
|
22 |
12 |
$117.65 |
| 90698 |
|
23 |
22 |
$96.46 |
| 90620 |
|
27 |
24 |
$73.31 |
| 90696 |
|
15 |
13 |
$63.31 |
| 90649 |
|
13 |
13 |
$56.62 |
| 90700 |
|
15 |
12 |
$48.17 |
| 90710 |
|
15 |
13 |
$45.43 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
24 |
17 |
$0.36 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
72 |
27 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
995 |
917 |
$0.00 |
| 90461 |
|
90 |
24 |
$0.00 |
| 90473 |
|
23 |
20 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,974 |
1,852 |
$0.00 |